APA (7th ed.) Citation

JM, R., C, M., AH, R., SM, R., MC, S., CS, Z., . . . I, S. (2022). Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA vaccination in Individuals With Underlying Immune Dysregulation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(1), e912. https://doi.org/10.1093/cid/ciab1024

Chicago Style (17th ed.) Citation

JM, Rocco, Mallarino-Haeger C, Randolph AH, Ray SM, Schechter MC, Zerbe CS, Holland SM, and Sereti I. "Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccination in Individuals With Underlying Immune Dysregulation." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 75, no. 1 (2022): e912. https://doi.org/10.1093/cid/ciab1024.

MLA (9th ed.) Citation

JM, Rocco, et al. "Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccination in Individuals With Underlying Immune Dysregulation." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 75, no. 1, 2022, p. e912, https://doi.org/10.1093/cid/ciab1024.